| answer text |
<p>It is right that patients should have access to cost-effective, innovative medicines
at a price that is affordable to the National Health Service. As explained in the
adjournment debate on 4 February, the Government is clear Crown Use is not a quick
or easy solution but it is important we consider all options.</p><p> </p><p>The manufacturer,
Vertex, needs to agree the very generous offer that has been made so that patients
who need Orkambi are able to access it on the NHS. This is in the best interests of
patients.</p>
|
 |
